Big pharma failing to develop urgent drugs for poorest countries

Julia Kollewe of the Guardian covers the latest Access to Medicine Index: "most firms focus on infectious diseases such as HIV/Aids, malaria and tuberculosis but had failed to focus on other serious ailments." 

Jayasree K Iyer, Executive Director of the Access to Medicine Foundation, is quoted as saying “There have been massive improvements in global health in the past decades, with all major pharmaceutical companies taking action. To close the gaps that remain, a greater diversity of companies must get involved and stay engaged for the long haul.”